U.S. markets close in 1 hour 21 minutes
  • S&P 500

    3,891.43
    -10.39 (-0.27%)
     
  • Dow 30

    31,513.85
    -21.66 (-0.07%)
     
  • Nasdaq

    13,443.94
    -144.89 (-1.07%)
     
  • Russell 2000

    2,245.38
    -29.94 (-1.32%)
     
  • Crude Oil

    59.75
    -0.89 (-1.47%)
     
  • Gold

    1,733.40
    +10.40 (+0.60%)
     
  • Silver

    26.79
    +0.11 (+0.42%)
     
  • EUR/USD

    1.2088
    +0.0028 (+0.23%)
     
  • 10-Yr Bond

    1.4140
    -0.0320 (-2.21%)
     
  • GBP/USD

    1.3961
    +0.0040 (+0.29%)
     
  • USD/JPY

    106.7300
    0.0000 (0.00%)
     
  • BTC-USD

    47,845.30
    -662.95 (-1.37%)
     
  • CMC Crypto 200

    955.13
    -31.52 (-3.19%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

H.C. Wainwright Sticks to Their Buy Rating for Galapagos NV

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.


H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Galapagos (NASDAQ:GLPG) NV on Monday, setting a price target of $302, which is approximately 39.09% above the present share price of $217.12.

Chattopadhyay expects Galapagos NV to post earnings per share (EPS) of $0.00 for the second quarter of 2020.

The current consensus among 11 TipRanks analysts is for a Moderate Buy rating of shares in Galapagos, with an average price target of $230.4.
The analysts price targets range from a high of $302 to a low of $154.

In its latest earnings report, released on 12/31/2019, the company reported a quarterly revenue of $119.27 million and a net profit of -$22.73 million. The company's market cap is $14.07 billion.

According to TipRanks.com, H.C. Wainwright analyst Debjit Chattopadhyay is a 4-star analyst with an average return of 6.8% and a 43.4% success rate.

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.